Group 1 - The company reported a revenue of HKD 3.296 billion for the first half of 2025, representing a year-on-year decline of 4.4% [1] - The profit attributable to the company's owners was HKD 20.603 million, also down 4.3% year-on-year [1] - The basic earnings per share stood at HKD 0.035 [1]

Financial Performance - Revenue for the six months ended June 30, 2025, was HKD 3,296,178, a decrease of 4.4% compared to HKD 3,446,519 in 2024[2] - Gross profit for the same period was HKD 339,512, down 8.9% from HKD 372,519 in 2024[2] - Net profit for the period was HKD 36,435, slightly up by 2.4% from HKD 35,594 in 2024[2] - Basic and diluted earnings per share were 3.5 HK cents, compared to 3.6 HK cents in 2024[2] - Total comprehensive income for the period was HKD 41,099, an increase of 30.4% from HKD 31,538 in 2024[5] - The company reported a profit before tax of HKD 52,835 for the six months ended June 30, 2025, compared to HKD 46,861 for the same period in 2024, reflecting an increase of 12.5%[16] - The company reported a pre-tax profit of HKD 26,648,000 for the six months ended June 30, 2025, compared to HKD 27,559,000 in 2024, reflecting a decrease of 3.3%[5] - For the six months ending June 30, 2025, the company reported revenue of HKD 3,300,000,000 and net profit of HKD 36,400,000, showing slight improvement compared to the same period last year[56] Assets and Liabilities - Non-current assets totaled HKD 1,127,238 as of June 30, 2025, a slight decrease from HKD 1,127,707 at the end of 2024[6] - Current assets amounted to HKD 4,916,116, down from HKD 4,953,307 at the end of 2024[6] - Current liabilities were HKD 3,662,784, a decrease from HKD 3,710,371 at the end of 2024[6] - Total assets as of June 30, 2025, amounted to HKD 6,043,354, a slight decrease from HKD 6,081,014 as of December 31, 2024[15] - Total liabilities were HKD 3,742,884, showing a decrease from HKD 3,791,471 as of December 31, 2024[15] - The company’s asset-to-liability ratio stands at 47.7%, ensuring operational stability with a current ratio of 1.3[63] Equity and Investments - The company's equity increased to HKD 2,300,470 as of June 30, 2025, compared to HKD 2,289,543 at the end of 2024[7] - The company recognized government subsidies totaling HKD 1,464 during the six months ended June 30, 2025, compared to HKD 2,061 in the same period of 2024[17] - The company has a total of HKD 2,574,000,000 in unused bank and financial institution credit available for operational funding and trade financing[47] - The company is focused on prudent capital allocation, balancing growth investments with shareholder value maintenance[64] Operational Highlights - Revenue from construction services was HKD 3,084,374, accounting for approximately 93.6% of total revenue, while product sales contributed HKD 211,804[16] - Employee benefits expenses, including director remuneration, increased to HKD 637,205,000 in 2025 from HKD 572,189,000 in 2024, representing an increase of 11.4%[19] - The company reported a decrease in depreciation of property, plant, and equipment to HKD 37,273,000 in 2025 from HKD 41,617,000 in 2024, a decline of 10.5%[19] - The company’s interest expenses on bank loans and overdrafts increased to HKD 27,477,000 in 2025 from HKD 24,041,000 in 2024, an increase of 10.1%[5] Segment Performance - Revenue from the aviation segment was HKD 138,000,000, a decrease from HKD 286,000,000 in 2024, with operating profit dropping to HKD 2,000,000 from HKD 18,800,000[42] - The plastics and chemicals trading segment recorded revenue of HKD 163,000,000, down 34% from HKD 246,000,000 in 2024, resulting in an operating loss of HKD 1,900,000 compared to a profit of HKD 4,100,000 in 2024[44] - The foundation piling and geological survey business generated revenue of HKD 1,200,000,000, an increase of 9.2% year-on-year, with operating profit rising to HKD 75,500,000[57] - The building construction segment contributed revenue of HKD 429,000,000 but recorded an operating loss of HKD 27,500,000 due to slow project progress and repair work[60] Strategic Initiatives - The company is diversifying into disinfectants and hygiene products, with the global disinfectant market growing at over 10% annually, and the Hong Kong household cleaning market expected to grow by 1.97% annually from 2025 to 2029[44] - The company is expanding its "Yahorun" disinfectant and hygiene business and developing eco-friendly plastic products[45] - The company is investing in AI automation to enhance construction safety and efficiency across departments[57] - The company is expanding its electric vehicle charging network and building data center infrastructure as part of its future-oriented strategy[59] Governance and Compliance - The company has complied with all relevant provisions of the Corporate Governance Code, except for provision B.2.2, which states that each director must retire at least once every three years[69] - The Audit Committee has held regular meetings since its establishment, with at least two meetings per year to review and supervise the financial reporting process and internal controls[70] - No shares of the company were purchased, sold, or redeemed by the company or any of its subsidiaries during the six months ending June 30, 2025[71]

Core Viewpoint - Jianlian Group (00385.HK) is set to hold a board meeting on August 28, 2025, to approve its interim results for the six months ending June 30, 2025 [1] Related Events - Jianlian Group (00385.HK) plans to hold a board meeting on August 28 to approve its interim results [1] - Jianlian Group (00385.HK) has appointed Dr. Wang Yan as a non-executive director [1]

香港 交易及結算 所有限公司 及香港聯合 交易所有限 公司對本公 佈之內容概 不負責，對 其準 確性或完整 性亦不發表 任何聲明， 並明確表示 ，概不對因 本公佈全部 或任何部份 內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 香港，二零二五年八月十八日 於 本 公 佈 日 期，董 事 會 由 八 名 董 事 組 成， 包 括 三 名 執 行 董 事 王 承 偉 先 生 、 陳 遠 強 先 生 及 林 炳 麟 先 生；兩 名 非 執 行 董 事 王 妍 醫 生 及 胡 志 釗 先 生；以 及 三 名 獨 立 非 執 行 董 事 詹 伯 樂 先 生 、 唐 景 炘 先 生 及 陳 子 君 女 士 。 *僅 供 識 別 董 事 會 會 議 通 知 建 聯 集 團 有 限 公 司 （ 「 本 公 司 」 ） 之 董 事 會 （ 「 董 事 會 」 ） 宣 佈 ， 本公司謹訂於二零二五年八月二十八日 (星期四 )舉行董事會會議，藉 以（其中包括）批准本公司及其附屬公司截至二零二五年六月三十日 止六個月之中期業績。 承 董 事 會 命 盧 潤 生 公 司 秘 書 * (於 百 慕達 註 冊成 立 之 有限 公 ...

建联集团(00385)发布公告，自2025年8月14日起，王妍医生获委任为本公司非执行董事。 ...

智通财经APP讯，建联集团(00385)发布公告，自2025年8月14日起，王妍医生获委任为本公司非执行董 事。 ...

格隆汇8月14日丨建联集团(00385.HK)公布，自2025年8月14日起，王妍医生获委任为公司非执行董事。 ...

王承偉先生（主席） 陳遠強先生（副主席及董事總經理） 林炳麟先生 非執行董事 王妍醫生 胡志釗先生 獨立非執行董事 * (於 百 慕 達 註 冊 成 立 之 有 限 公 司 ) （ 股 份 代 號 （股 份 代 號 ：385） 董事名單及其角色與職能 建聯集團有限公司董事會（「董事會」）成員載列如下： 執行董事 唐景炘先生（主席） 胡志釗先生 詹伯樂先生 薪酬委員會 陳子君女士（主席） 唐景炘先生 陳遠強先生 王承偉先生 詹伯樂先生 提名委員會 陳子君女士（主席） 詹伯樂先生 唐景炘先生 王承偉先生 林炳麟先生 香港，二零二五年八月十四日 *僅 供 識 別 詹伯樂先生 唐景炘先生 陳子君女士 董事會設立三個委員會，董事會成員於各委員會之司職載列如下： 審核委員會 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任 何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 * （於百慕達註冊成立之有限公司） （股份代號：385） 委任非執行董事 董事會欣然宣佈，自二零二五年八月十四日起，王妍醫生獲委任為本公司非執 行董事。 建聯集團有限公司（「本公司」，連同其附屬公司統稱為「本集團」）董事（「董事」）會 （「董事會」）欣然宣佈，自二零二五年八月十四日起，王妍醫生（「王妍醫生」）獲委 任為本公司非執行董事。 王妍醫生，五十九歲，持有華盛頓大學醫學博士學位及高階健康管理碩士學位及 美國內科醫學委員會文憑。 王妍醫生於求是科技基金會執行委員會擔任職務。彼現時為香港大學李嘉誠醫學 院家庭醫學及基層醫療學系之榮譽副教授，亦為華盛頓大學醫療中心之前任醫療 參謀長。 王妍醫生為建業實業有限公司（股份代號：216，「建業實業」）之非執行董事以及 Lucky Year Finance Limited及建業發展（集團）有限公司之董事，該等公司均被視 為擁有同一批173,093,695股本公司 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對 其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部分 內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 電話 : (852) 2980 1333 傳真 : (852) 2810 8185 由二零二五年八月十二日起，有關本公司之股份過戶及登記手續將由卓佳 證券登記有限公司辦理。於二零二五年八月十一日下午四時三十分後仍未 領取之股票，可於二零二五年八月十二日起從卓佳證券登記有限公司領 取。 於本公佈日期，董事會由七名董事組成，包括三名執行董事王承偉先生、陳遠強先生 及林炳麟先生；一名非執行董事胡志釗先生；以及三名獨立非執行董事詹伯樂先生、 唐景炘先生及陳子君女士。 * 僅供識別 承董事會命 盧潤生 公司秘書 香港，二零二五年八月六日 更改香港股份過戶登記分處 建 聯 集 團 有 限 公 司 ( 「 本 公 司 」 ) 之 董 事 會 ( 「 董 事 會 」 ) 宣 佈 自二零二五年八月十二日起，本公司之香港股份過戶登記分處將更改為: - 卓佳證券登記有限公司 香港夏慤道 16 號 遠東金融中心 17 樓 ...